The platform combines the Dual Energy THERMOCOOL SMARTTOUCH SF Catheter, an irrigated contact-force sensing catheter, with the TRUPULSE Generator to enable delivery of both radiofrequency (RF) and pulsed field (PF) energy through a single catheter-based solution.i Designed to support precise and insight-driven ablation, the platform enables electrophysiologists to leverage both pulsed field and radiofrequency energy within the same procedure.i
Built on the THERMOCOOL SMARTTOUCH SF platform, a globally trusted catheter with extensive clinical validation and more than a million patients treated worldwide, DE STSF combines a familiar point-by-point workflow with the flexibility to tailor treatment approaches across a broad range of cardiac ablation procedures.i Leveraging the power of CARTO integration, ultra high-density mapping solutions and intracardiac ultrasound imaging, the platform delivers advanced electro-anatomical mapping, catheter visualization, contact-force feedback and PF/RF Index guidance. Together, these capabilities are designed to support procedural control and reproducible lesion creation.
“DE STSF is a welcome addition to the EP lab because it allows physicians to incorporate new technology based on the gold RF standard smarttouch SF platform while maintaining familiar workflows with greater versatility by seamlessly switching between RF and PFA,” said Nicolas Derval1, M.D., Bordeaux, France. “This flexibility also provides greater ability to adjust treatment to different patient anatomies, clinical needs and procedural goals while increasing safety in ablating the posterior wall for example.i”
“No two atrial fibrillation patients are the same, which is why personalized treatment and procedural versatility matter,” said Ricardo Martin, President EMEA, Electrophysiology, MedTech, Johnson & Johnson. “The launch of the Dual Energy THERMOCOOL SMARTTOUCH SF Platform reflects our continued commitment to providing physicians with a broad range of treatment options. As the latest addition to our integrated pulsed field ablation portfolio, it combines the familiarity of the world’s leading radiofrequency catheter with the versatility of pulsed field ablation, giving physicians greater confidence to tailor treatment to each patient’s needs.”
Clinical data supporting the platform include 12-month findings from the SmartfIRE first-in-human study, which demonstrated 86.9% effectiveness among patients treated with high adherence to the recommended workflow and PF/RF Index guidance. The study also demonstrated clinically meaningful improvements in quality of life and reductions in cardiovascular-related hospitalizations and antiarrhythmic drug use.ii
The DE STSF Platform is supported by the company’s integrated electrophysiology ecosystem, bringing together mapping, intracardiac ultrasound, therapy technologies and clinical support solutions designed to help physicians navigate increasingly complex ablation procedures.
Cardiovascular Solutions from Johnson & Johnson MedTech
Across Johnson & Johnson, we are tackling the world’s most complex and pervasive health challenges. Through a cardiovascular portfolio that provides healthcare professionals with advanced mapping and navigation, miniaturized tech, and precise ablation we are addressing conditions with significant unmet needs such as heart failure, coronary artery disease, stroke, and atrial fibrillation. We are the global leaders in heart recovery, circulatory restoration, and the treatment of heart rhythm disorders, as well as an emerging leader in neurovascular care, committed to taking on two of the leading causes of death worldwide in heart failure and stroke. For more, visit this website
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity.
For more information please visit, https://www.jnjmedtech.com
